The high frequency of SF3B1 mutations and their progressive stimulation in many cancers reflect the critical roles of SF3B1 protein in the recognition and selection of intronic splice sites and branch sites and thereby accurate gene expression. The gene discussed is SF3B1; the disease is cancer.